"He had a terrible end to his life, a terrible death filled with fear and anxiety and pain. And we feel that this was so preventable." ...
After a heart attack, the heart struggles to recoup and maintain energy. One-third of patients develop heart failure as a ...
A secondary analysis of the SOUL trial shows significant improvement in heart failure outcomes with oral semaglutide vs placebo, consistent with the injectable formulation.
After a heart attack, the heart struggles to recoup and maintain energy. One third of patients develop heart failure as a ...
Oral semaglutide reduces risk for heart failure events among patients with T2D and preexisting heart failure, according to the SOUL trial.
Prior authorization, a process that requires physicians to obtain approval from health care insurers before certain treatments are covered, may keep patients from filling prescriptions for two ...
Where drinking water comes from and what it contains may affect Parkinson's disease risk, a recent study suggests.
Want to give your heart a little TLC? Across the country, nearly half of all adults have some form of cardiovascular disease, the leading cause of death for American men and women. With numbers like ...
A major international trial has found that daily fish oil supplements significantly reduced life-threatening cardiovascular events in dialysis patients. People who took four grams per day had a 43% ...
About 40% of East Asians suffer from alcohol intolerance, known as “Asian Flush Syndrome,” caused by an ALDH2 genetic mutation. Beyond facial flushing, this mutation carries serious cardiovascular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results